Metraipolis › archive › dc_ceb8a915cf36

Safety, tolerability, and pharmacokinetics of a 2 g subcutaneous dose of ceftriaxone as an alternative to intravenous delivery — Europe PMC PMID:41277849

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41277849
DOI
10.1128/aac.01081-25
License (as archived)
solo-consultazione
Archived
2026-11-08T07:49:44.911Z
SHA-256 of the archived text
a395f9a5ca7fbaa42e5f3ff0d180a70321d6056e871000f59bd03dab0e1b0f32
Stable URL of this page
https://metraipolis.com/documento/dc_ceb8a915cf36

How to cite

Safety, tolerability, and pharmacokinetics of a 2 g subcutaneous dose of ceftriaxone as an alternative to intravenous delivery — Europe PMC PMID:41277849 — Europe PMC (en), https://europepmc.org/article/MED/41277849 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ceb8a915cf36 (Metraipolis archive dc_ceb8a915cf36, sha256 a395f9a5ca7fbaa42e5f3ff0d180a70321d6056e871000f59bd03dab0e1b0f32)
BibTeX
@misc{dcceb8a915cf36,
  title = {Safety, tolerability, and pharmacokinetics of a 2 g subcutaneous dose of ceftriaxone as an alternative to intravenous delivery — Europe PMC PMID:41277849},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41277849},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ceb8a915cf36; sha256 a395f9a5ca7fbaa42e5f3ff0d180a70321d6056e871000f59bd03dab0e1b0f32},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41277849. Agents can read the archived copy with the MCP tool read_document.